Understanding MAT access in the context of unused MAT capacity in the United States: when increasing rural MAT capacity is not enough.  Mun CC, Zambrano R, Tallman E, Schuler H, Bresani E, Meyers K.  Subst Abuse Treat Prev Policy. 2024 D…

Organization of primary care and early MOUD discontinuation.  Harris RA, Kearney M, Keddem S, Calderbank T, Tomczuk L, Clapp J, Perrone J, Kranzler HR, Long JA, Mandell DS.  Addict Sci Clin Pract. 2024 Dec 19;19(1):96. doi: 10.1186/s1372…

Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial.  Crepeault H, Ti L, Bach P, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Socias ME. …

Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS trial).  Palazzo L, Dorsey CN, Mogk J, Beatty T, King D, Stefanik-Guizlo K, Key D, Matson TE, Shea M, Cald…

Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizations.  Knudsen HK, Andrews-Higgins S, Back-Haddix S, Lofwall MR, Fanucchi L, Walsh SL.  Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-544…

Barriers in Office-Based Opioid Treatment in Rural United States.  Satyasi SK, Stewart C, Parimi K, Sukpraprut-Braaten S, Ashraf N.  Cureus. 2024 Nov 10;16(11):e73373. doi: 10.7759/cureus.73373. PMID: 39664135; PMCID: PMC11633845. https…